Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA sends fewer drug promotion action letters in 2015--but is that a good thing for pharma?
FDA sends fewer drug promotion action letters in 2015--but is that a good thing for pharma?
FDA sends fewer drug promotion action letters in 2015--but is that a good thing for pharma?
Submitted by
admin
on January 6, 2016 - 3:28pm
Source:
Fierce Pharma Marketing
News Tags:
FDA
OPDP
digital media
Headline:
FDA sends fewer drug promotion action letters in 2015--but is that a good thing for pharma?
Do Not Allow Advertisers to Use My Personal information